Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Fractures, particularly at the lower extremities and hip, are a complication of diabetes. In both type 1 (T1D) and type 2 diabetes (T2D), fracture risk is disproportionately worse than that predicted from the measurement of bone mineral density. Although an explanation for this discrepancy is the presence of organic matrix abnormalities, it has not been fully elucidated how advanced glycation endproducts (AGEs) relate to bone deterioration at both the macroscopic and microscopic levels. We hypothesized that there would be a relationship between skeletal AGE levels (determined by Raman microspectroscopy at specific anatomical locations) and bone macroscopic and microscopic properties, as demonstrated by the biomechanical measures of crack growth and microindentation respectively. We found that in OVE26 mice, a transgenic model of severe early onset T1D, AGEs were increased by Raman (carboxymethyl-lysine [CML] wildtype (WT): 0.0143 ±0.0005 vs T1D: 0.0175 ±0.0002, p = 0.003) at the periosteal surface. These differences were associated with less tough bone in T1D by fracture mechanics (propagation toughness WT: 4.73 ± 0.32 vs T1D: 3.39 ± 0.24 NM/m1/2, p = 0.010) and by reference point indentation (indentation distance increase WT: 6.85 ± 0.44 vs T1D: 9.04 ± 0.77 μm; p = 0.043). Within T1D, higher AGEs by Raman correlated inversely with macroscopic bone toughness. These data add to the existing body of knowledge regarding AGEs and the relationship between skeletal AGEs with biomechanical indices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig 3 Matrix Properties by Raman Spectroscopy in femoral bones. Raman microspectroscopic measurement showed a decrease in mineral/matrix ratio [v2PO4/Amide III] (panel A) and in relative lipids content [lipids/Amide III] (panel B) in diabetic OVE26 mice (n = 6) as compared to wildtype FVB mice (n = 6). Mineral maturity/crystallinity [FWHH V1PO4] did not differ (panel C) in diabetic OVE26 mice. In contrast, relative pyridinoline content was increased in diabetic OVE26 mice (panel D), while there was no difference in relative proteoglycan content [PG/ Amide III] (panel E). The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.](https://figures.cochat.ai/paper-figures/19d815113b7c41d284e0127700183b42/advanced-glycation-endproducts-and-bone-material-properties-in-type-1-diabetic-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and that this difference may be related to heightened accumulation of AGEs in diabetic bone (75).”
From Bone Mechanical Properties in Healthy and Diseased States (2018) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,417
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511 · cited 2×
“The AGEs content was normalized against the CH peak ~1450 cm, as this peak reflects lipid content [18] along with collagen content to a better extent than Amide III (which is mostly representative of collagen), and both collagen and lipids can serve as substrata for AGEs formation [8].”
Vestergaard, P. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,808 · cited 4×
“Surprisingly, fracture risk is not fully accounted for in either type 1 (T1D) or type 2 (T2D) diabetes by measurement of bone mineral density (BMD) by dual energy X-ray absorptiometry [1].”
InfluentialReference database of Raman spectra of biological molecules
De Gelder, J., De Gussem, K., Vandenabeele, P., & Moens, L. (2007) · Journal of Raman Spectroscopy · doi:10.1002/jrs.1734 · Cited by 1,425 · cited 1×
“Molecular structures including rings (similar but not identical to pentosidine) exhibit a Raman band ~1490 cm [42].”
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440109 · Cited by 1,243
Raman spectroscopy of lipids: A review
Czamara, K., Majzner, K., Pacia, M. Z., Kochan, K., Kaczor, A., & Baranska, M. (2015) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4607 · Cited by 1,089 · cited 1×
“Additionally in this spectral region there are no contributions from either collagen, lipids, or proteoglycans [16, 41].”
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918 · cited 2×
“AGEs are markedly increased in patients with diabetes [7], forming non-enzymatic cross-links within and across collagen fibers [9].”
Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834 · cited 1×
“We did not perform Raman measurements further into the surface because the bone was not embedded, as this might have disturbed the lipids and thus AGEs formation [38].”
Accelerated age-related browning of human collagen in diabetes mellitus.
Monnier, V. M., Kohn, R. R., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.583 · Cited by 671 · cited 1×
“In diabetes, the accumulation of advanced glycation endproducts (AGEs) in Type I collagen is elevated [2, 3].”
Cited by
Bone Mechanical Properties in Healthy and Diseased States
Morgan, E. F., Unnikrisnan, G. U., & Hussein, A. I. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121139 · Cited by 1,026
“evidence also indicates that diabetes is associated with lower bone toughness as compared with normal cortical bone (70, 74) and that this difference may be related to heightened accumulation of AGEs in diabetic bone (75).”
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
“AGEs have also been linked to thrombogenicity [181], kidney fibrosis [182], structural bone damage [183] and neurotoxicity [184].”
BackgroundAdvanced glycation end products, diabetes, and bone strength
Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0332-1 · Cited by 215
The Role of Matrix Composition in the Mechanical Behavior of Bone
Ünal, M., Creecy, A., & Nyman, J. S. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0433-0 · Cited by 158
Vibrational spectroscopic techniques to assess bone quality
Paschalis, E. P., Gamsjaeger, S., & Klaushofer, K. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4019-y · Cited by 157
“signal below instrumental detection limit [170].”
Self-citation
Metadata
- Authors
- Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D.
- Affiliations
- Columbia University (US)
- Hanusch Hospital (AT)
- Rensselaer Polytechnic Institute (US)
- Corresponding author
- Rubin, Mishaela R.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-05-03
- Volume
- 11
- Issue
- 5
- Pages
- e0154700
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4854398
- OpenAlex
- W2346226609
- Cited by
- 90
- References
- 57
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 6 · 2023: 13 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 6 · 2016: 3
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-07-21)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Columbia University Irving Institute for Clinical and Translational Research (CTSA/CTO pilot award)
- National Institutes of Health (AR 49635, AG 20618)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- advanced glycation end products, type 1 diabetes, bone biomechanics, fracture risk, carboxymethyllysine, bone toughness, microindentation, micro-Raman spectroscopy, bone organic matrix
- MeSH terms
- Animals, Biomechanical Phenomena, Bone and Bones, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Female, Bone Density, Glycation End Products, Advanced, Fractures, Bone, Mice, Mechanical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice. https://app.cochat.ai/papers/10.1371/journal.pone.0154700
- The paper
- Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D. (2016). Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0154700
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.